OTF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. OTF is in a clear short-to-long-term downtrend (bearish moving-average stack and MACD below zero), and Intellectia signals show no buy setup today. With weak near-term pattern odds (-5.56% next week) and no news catalyst, the risk/reward is not attractive for an impatient buyer at the current pre-market $13.55. Better to wait for a trend reversal/hold above the pivot (13.85) before buying.
Trend/structure: Bearish (SMA_200 > SMA_20 > SMA_5), indicating the stock remains below key averages and sellers control the broader trend. Momentum: MACD histogram -0.0885 (below 0) and only contracting slightly—bearish momentum is easing but not reversed. RSI: RSI_6 = 34.1 (near oversold/weak), which can allow a short bounce, but it is not a confirmed reversal signal. Levels: Current pre-market ~13.55 is below the pivot 13.851 (bearish bias). Near-term support S1 13.294 (break risks S2 12.949). Resistance levels: R1 14.409 then R2 14.754. Pattern-based odds: ~40% chance of +2.83% next day, but expected drift negative over the next week (-5.56%) and month (-1.3%).
Intellectia Proprietary Trading Signals
2025/Q3 showed strong YoY growth (Revenue +115.38%, Net Income +96.54%, EPS +92.31%), supporting a fundamentally improving profile.
Analyst targets ($14–$15 range) imply upside from current ~$13.55 if the stock stabilizes.
RSI near-oversold can support a short-term relief bounce if support holds (13.29 area).
with MACD still below zero—no confirmed reversal.
can create uncertainty without a clear edge today.
Latest reported quarter: 2025/Q3. Revenue rose to 426,861,000 (+115.38% YoY), Net Income to 234,935,000 (+96.54% YoY), and EPS to 0.50 (+92.31% YoY). Growth is strong year-over-year, but price action suggests the market remains cautious near-term (rates/credit-cycle sensitivity).
Recent trend: Neutral-to-cautious. RBC initiated (2025-12-05) at Sector Perform with $15 PT, highlighting differentiation in enterprise software lending but noting potential below-peer ROE in 2026 while leverage ramps. BofA (2025-11-28) maintained Neutral and lowered PT to $14 from $15 on industry multiple contraction tied to lower rates/private credit concerns and a lower 2026 earnings forecast. Wall Street pros: differentiated niche, potential ROE expansion story, PTs above current price. Wall Street cons: below-peer ROE risk in 2026, sector multiple pressure, and earnings/credit-cycle sensitivity.
